Henry Schein (HSIC) Goldman Sachs 45th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs 45th Annual Global Healthcare Conference summary
1 Feb, 2026Dental market trends and performance
Early 2024 saw a slow start due to lingering effects from a cyber incident, adverse weather, and high flu rates, but recovery began in February and stabilized through April and May.
Patient traffic is stable, with about 90% of practices operating at capacity, limiting immediate growth potential.
Market expansion is expected as more dental schools open and new dentists enter the field over the next few years.
Unemployment rates are a key macro factor; low unemployment supports dental care access and consumables demand.
Interest rates impact equipment financing and high-cost procedures, with targeted promotions helping offset higher rates.
International market dynamics
Germany remains strong in implants with mid-single-digit growth and some growth in equipment servicing, while other segments are flat.
Australia faces headwinds as post-pandemic incentives expire and rising interest rates squeeze disposable income.
Equipment and service trends
Standard equipment demand surged post-pandemic due to pent-up demand and practice expansions, now leveling off to mid-single-digit growth.
Service plans are being marketed more, with new app-based tools enabling rapid technician response and improved customer retention.
Practice formation is expected to grow as more dentists graduate, especially within DSOs, supporting future equipment and merchandise demand.
Latest events from Henry Schein
- Q1 2026 delivered strong sales, margin, and EPS growth, with guidance and value initiatives reaffirmed.HSIC
Q1 20265 May 2026 - $13.2B FY2025 sales, digital transformation, and high-margin growth drive long-term value.HSIC
Corporate presentation5 May 2026 - Proxy details CEO transition, board reduction, pay-for-performance, and key governance votes.HSIC
Proxy filing8 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and majority voting.HSIC
Proxy filing8 Apr 2026 - $13.2B in 2025 sales with strong specialty, technology, and high-margin business growth.HSIC
Corporate presentation13 Mar 2026 - Dental segment growth, digital innovation, and leadership changes drive optimism for 2026.HSIC
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Operational shift, AI innovation, and specialty growth drive margin and market share gains.HSIC
Leerink Global Healthcare Conference 20269 Mar 2026 - Record sales and earnings growth in Q4 2025, with a strong outlook for 2026.HSIC
Q4 202524 Feb 2026 - Q2 2024 sales up 1.1% to $3.14B; net income and EPS fell, and 2024 guidance was reduced.HSIC
Q2 20242 Feb 2026